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ABSTRACT 
Patient engagement, or active participation and involvement in one’s health care, has been 
beneficially related to health outcomes and lower health care costs. The purpose of this study was 
to elucidate the relationship between patient engagement, pursuing lifestyle behavior changes 
(weight loss and tobacco cessation), and the impact of receiving genetic information for hereditary 
cancer syndromes. We hypothesized that higher baseline engagement scores and receiving a 
pathogenic variant result would be associated with positive behavior changes. It was also expected 
that receiving pathogenic variant results would be associated with increased engagement scores. 
Patients seen in the UPMC Hereditary GI Tumor Program were verbally administered the Altarum 
Consumer Engagement (ACE) Measure survey to assess patient engagement prior to their initial 
appointment. Participants were then contacted via phone three to five months after their initial 
appointment to repeat the ACE measure, as well as a Lifestyle Questionnaire if applicable. A total 
of 195 participants were included in the analyses, 51 of whom were overweight at their initial 
appointment and 15 of whom were current smokers at their initial appointment. Two sample T-
tests, linear and logistic models, and Fisher’s exact test were used to test associations. It was found 
that having a higher baseline Navigation score within the ACE measure was associated with an 
individual being less likely to lose weight. Tobacco cessation was not associated with baseline 
total engagement (ACE). A pathogenic variant result did not make an individual more or less 
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 v 
engaged in their health, lose weight, or quit smoking compared to those with no pathogenic variant. 
Additionally, participants were found to have significantly greater engagement levels after 
receiving genetic counseling. Genetic counseling may be an effective healthcare intervention to 
increase patient engagement, and thus ultimately lead to improved public health, decreased 
healthcare dollars, and beneficial patient outcomes.  
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1 
 INTRODUCTION 
Patient engagement is a new field of study that strives to understand the implications of being 
involved in one’s health care.1 Research has found that more highly engaged patients were 
significantly less likely to be obese, to smoke, and to have an emergency department visit or a 
hospital stay within the past 12 months.2  Further, patients with lower engagement levels had health 
care costs that were up to eight times greater than those with the higher engagement levels.3  
Two major public health burdens, obesity and tobacco smoking, have been previously 
associated with patient engagement.1 It was previously found that individuals who were obese 
were 25-40% less likely to receive colorectal screening compared to those who were not obese.4,5 
Another study reported that patients who had higher current levels of engagement were 1.62 times 
more likely to have pursued a tobacco quit attempt over the past year compared to those with lower 
engagement levels.6 Genetic counseling is another field that is directly related to patient 
engagement.7 Genetic counseling has also previously been found to increase, knowledge about 
health, satisfaction with health care experiences, and involvement with the health care system, as 
well as decrease cancer-related worry and perceived risk.8,9  
The participant population included all patients seen in the Hereditary GI Tumor Program 
and who consented to participate in the study. At the time of their initial appointment, 
participants were verbally administered the Altarum Consumer Engagement (ACE) Measure 
survey to assess individual healthcare engagement. After completing the survey, the participants 
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next received genetic counseling and a consult with a gastroenterologist who specializes in 
hereditary GI cancer syndromes. Patients insured by UPMC Health Plan who were overweight 
(BMI ≥ 30) or were current smokers were given standard lifestyle modification reading material, 
as well as a Prescription for Wellness to a tobacco cessation or weight loss health coaching 
program if they were interested. Patients who were overweight or used tobacco and had a 
different insurer were given only the standard of care reading material for lifestyle changes. All 
participants were then contacted via phone three to five months after their initial office 
appointment to repeat the ACE measure survey. Individuals who were overweight (BMI ≥ 30) 
and individuals who were current tobacco users at the time of their initial visit were also asked to 
complete the Lifestyle Questionnaires, either the weight loss questionnaire or the smoking 
cessation questionnaire, as appropriate, during the post follow up phone call. 
This study aims to elucidate the relationship between patient engagement, lifestyle 
behavior changes, and the impact of receiving genetic information for hereditary cancer 
syndromes after a genetic counseling appointment. This research can serve to help identify 
effective public health interventions that can be integrated into a clinical setting to identify 
individuals at risk for poor health outcomes and to further tailor clinical care. Further 
understanding these associations has the potential to ultimately improve public health and may 
lead to lower healthcare costs. 
The specific aims and hypotheses of this study include: 
Aim 1: To investigate the impact of an individual’s baseline engagement in their health, as 
measured by the Altarum Consumer Engagement (ACE Measure), on lifestyle behavior 
outcomes for tobacco cessation and weight loss before and after genetic counseling.  
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Hypothesis: Individuals who have higher engagement scores will be more likely 
to change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals who have lower engagement scores.  
Aim 2: To compare engagement and behavioral changes between individuals with a 
pathogenic variant versus those with no pathogenic variant. 
Hypothesis 1: Individuals who have a pathogenic variant will be more likely to 
change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals who have no pathogenic variant.   
Hypothesis 2: Individuals who have a pathogenic variant will have increased 
engagement scores after a genetic counseling session compared to individuals who 
have no pathogenic variant.  
1.1 LITERATURE REVIEW 
1.2 PATIENT ENGAGEMENT 
1.2.1 Definition and Implications 
With the growing complexity of the health care system, greater demands are now being placed on 
patients to navigate, access, and understand health care. A new field of study, called patient 
engagement, has arisen to understand the implications of being involved in one’s health care. The 
term patient engagement was defined by Gruman et al. (2010) as “actions individuals must take to 
obtain the greatest benefit from the health care services available to them.”1 Factors that have been 
found to directly relate to patient engagement include health literacy, values and beliefs, education, 
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and socioeconomic status.10 Clinicians can also serve to increase patient engagement. Assessment 
tools that seek to measure how well clinicians are engaging patients in their health, known as 
patient-centered outcome measures, have been recently integrated into policy; the Affordable Care 
Act (ACA) addresses patient engagement and patient-centered outcomes. The ACA created 
patient-centered medical homes and provided incentives for hospitals to utilize patient portals, thus 
increasing opportunities for patients to become more engaged in the health care system.11 
Active participation and involvement in one’s health care is an important factor to consider 
when assessing health outcomes. One research group performed a meta-analysis of 365 studies 
and conducted 57 key informant interviews with researchers in the field of patient or consumer 
engagement to create an engagement behavior framework (EBF).1 The authors then coded 2,433 
sessions at seven different professional conferences from 2006-2007 that were related to patient 
education to quantify specific engaged behaviors of the EBF. It was concluded that engaged 
patients partake in behaviors ranging from knowledge of navigating health care, involvement in 
care decisions, and record keeping of medical information.1 The authors also found that certain 
disadvantaged groups such as the uninsured, those with low levels of health literacy, those with a 
lower education status, and older individuals are less likely to engage in health promoting 
behaviors.1 These groups of individuals, therefore; may not receive the same benefits as those who 
are more engaged since the behaviors of those who are active participants in their health may have 
implications for their well-being.  
Increased patient engagement can lead to better health outcomes as well as lower health 
care costs and thus better utilization of health care resources. Previous studies have found that 
when patients are more engaged in their own health, they are more likely to follow preventative 
measures, manage disease, and adhere to health recommendations.12, 2 In one study assessing the 
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activation of engaged patients and healthy behavior outcomes, a total of 25,047 patients who had 
attended a primary care visit within the past six months completed a Patient Activation Measure.2 
Patients with higher levels of engagement were significantly less likely to be obese, to smoke, and 
to have an emergency department visit or hospital stay within the past 12 months.2 They were also 
significantly more likely to have undergone a breast cancer screening, and to have normal lab 
results (A1c, HDL, and triglyceride levels).2 The authors concluded that patient engagement was 
associated with beneficial health behaviors as well as a better utilization of health care services, 
thus resulting in fewer costs. Another study found that implementing strategies to increase overall 
patient engagement resulted in beneficial clinical outcomes. A quasi-experimental trial gave a total 
of 11,797 patient’s access to their clinical records at three different hospitals.13 It was found that 
77-87% of the patients reported feeling more in control of their health and 60-78% of patients 
taking medications reported better adherence to their medications.13 Although patients reported 
few concerns, around 1-8% reported feelings of confusion, worry or offense.13 Overall, both 
clinicians and patient’s positive outcomes of granting patient’s access to their records, and thus 
increasing their engagement in their health.  
There are limited studies that have directly analyzed the extent to which patient 
engagement leads to lower health care costs. A longitudinal cross-sectional study analyzed Patient 
Activation Measure scores from 33,163 patients of a large health care system in Minnesota in 
relation to the patient’s total cost of non-inpatient care within the first six months of the following 
year.3 Adjusting for previous health conditions and risks, demographics, and the use of health care 
services outside of their system, it was found that higher patient engagement levels were positively 
associated with lower costs of care. More specifically, those with the lowest engagement levels 
had health care costs over the six-month period that were eight times higher than those with the 
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highest engagement levels. A follow up study analyzing data from the same health care system in 
Minnesota over a longer time period also found that individuals with higher engagement levels 
had total annual medical charges from their institution that were eight percent lower than those 
with the lowest engagement levels and had significantly better outcomes, including not smoking 
or not being obese, two years later.14 Measuring levels of engagement among patients may provide 
key information on outcomes that can be integrated into the clinic and reduce health care costs.  
1.2.2 The ACE Measure 
Given that measuring engagement levels can provide information that can be used to potentially 
improve patient health, health care systems and providers must consider which specific 
measurement tool is optimal. Only a small number of validated engagement measures exist, and 
most do not measure multiple factors of patient engagement.15 The Altarum Consumer 
Engagement (ACE) Measure™ (June 2015) is a validated patient measure created to provide a 
comprehensive, up to date measurement of a patient’s engagement in their health.15 Prior to the 
creation of the ACE, patient engagement measures only measured certain factors of patient 
engagement, such as clinical decision-making, patient autonomy, or activation.15 Additionally, no 
previous engagement measures factored in patient use of health care ratings and other tools to 
compare health care providers/services. In order to address the gap in engagement measures, the 
ACE measure utilized Gruman’s patient engagement definition, defined in the patient engagement 
section of this paper, in order to address all of the factors of engagement. The goal of the ACE is 
to assess both patient beliefs and actions in order to improve patient care.  
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The ACE measure is comprised of 12 statements and utilizes a 5-point Likert scale, ranging 
from “strongly disagree” to “strongly agree”. The tool has three different domains, with four 
questions comprising each domain. The domains are defined as: 
• “Commitment: confidence and ability to maintain a healthy lifestyle and manage 
one’s health. 
• Navigation: confidence and ability to ask about and participate in treatment 
decisions. 
• Informed Choice: Informed patterns of seeking and using information about health 
and healthcare.”15 
This measure has previously been found to be associated with health outcomes.16 A current 
study that utilized the ACE measure assessed the relationship between engagement levels and 
diabetes management and showed that the Commitment domain levels were associated with 
changes in glycated hemoglobin (HbA1c) levels.16 Those who had higher Commitment scores 
were significantly more likely to have improved HbA1c levels over time compared to those with 
lower Commitment scores.16 Clinicians could utilize this information to target interventions 
towards those with lower Commitment scores. Therefore, the ACE measure has the potential to be 
integrated into a clinical setting in order to improve patient care.  
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1.3 BEHAVIOR MODIFICATION 
1.3.1 Weight Loss 
Obesity is a major public health problem in the nation; during 2011-2014, around 36.5% of adults 
in the United States had a BMI of greater than or equal to 30.17 During the past couple of decades, 
the rates of this complex, chronic health problem have significantly grown across the nation.18 In 
1980, around 15% of adults in the United States ages 20-74 were obese.18 Factors that contribute 
to body size include genetics, physical inactivity, health conditions, and sociodemographic 
factors.19 Being overweight is associated with a variety of health problems including breast cancer, 
colon cancer, pancreatic cancer, type 2 diabetes, and cardiovascular disease.19 Okabayashi et al. 
(2012) conducted a meta-analysis of 23 studies that included a total of 105,190 individuals who 
had a BMI of less than 25 and 42,179 individuals who had a BMI of greater than or equal to 25. It 
was found that individuals with a BMI of greater than or equal to 25 have a 24% greater incidence 
of colorectal cancer.20 Maintaining a healthy weight and being physically active is an integral 
component of a healthy lifestyle.21 A prospective cohort study investigating the impact of weight 
loss on cancer incidence surveyed a total of 21,707 postmenopausal women who initially had never 
been diagnosed with cancer.22 After adjusting for age and BMI, the study found that women who 
had intentionally lost 20 pounds or more had a 14% decrease in obesity-related cancer incidence, 
a 9% decrease in colorectal cancer incidence, and a 19% decrease in breast cancer incidence 
compared to women who had never lost 20 pounds or more.22 In order to reach weight loss goals 
and subsequently decrease obesity-related health problems, individuals can pursue weight 
management intervention programs. 
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A review by Wu et al (2009) found that weight loss interventions that encompass both a 
physical activity and diet component are more successful in long-term weight loss.23 When an 
individual pursues weight loss interventions, there are several factors that can contribute to their 
success. A study was conducted to determine the predictors of long-term weight loss in participants 
who had participated in the Sibutramine Trial on Obesity Reduction and Maintenance, a 6-month 
weight-loss intervention comprised of Sibutramine treatment (an appetite suppressant) and dietary, 
fitness, and behavior advice.24 After the initial 6-month weight-loss intervention, a total of 261 
participants received advice from a dietician over an 18-month time period. It was found that initial 
weight loss and being physically active were predictors of long-term weight loss and accounted 
for 20% of the variation in weight maintenance.24 However, weight regain after completing a 
weight loss intervention is a common problem. Weight maintenance can be defined as an initial 
weight loss that has been sustained for over 6 months.25 Barte, Ter Bogt, and Bogers (2011) 
performed a meta-analysis and found that only around 54% of people maintain their weight a year 
after a weight loss intervention.25 Considering the factors that may make an individual more likely 
to lose weight and maintain that weight loss is important to inform the development of 
interventions.  
One such factor that may be associated with body size is patient engagement, as 
maintaining a recommended body weight is a behavior that is part of the engaged behavioral 
framework (EBF).1 Individuals who are obese face barriers to receiving heath care, such as the 
fear of negative attitudes from physicians and few accommodations for seating in a clinic.26 These 
factors have contributed to individuals choosing not to receive screening services such as 
mammograms and colonoscopies.4,5 Ferrante et al. (2006) conducted a study to assess the rates of 
colorectal screening in a primary care setting among individuals who were obese.4 Retrospective 
10 
chart reviews were completed on a total of 1,297 patients. It was found that individuals who were 
obese were 25% less likely to receive colorectal screening compared to those who were not obese.4 
Similarly, Messina et al. (2012) conducted a study to assess gender differences as well as attitudes 
towards colorectal cancer screening in individuals who were overweight. A random sample of 
people aged 50-75 years old who had never been diagnosed with colorectal cancer or colon polyps 
were surveyed by telephone.27 The authors reported that women who were overweight and obese 
were 40% less likely to receive colorectal screening compared to women who were not overweight 
or obese. Women, but not men, who were overweight and obese were half as likely to know that 
increased body weight can be associated with colorectal cancer and to report worry about 
developing colorectal cancer. No differences were found between men and rates of colorectal 
screening. Therefore, being overweight, especially for women, may hinder an individual’s ability 
to engage in behaviors such as receiving cancer screening that will contribute to their health. As 
obesity is a risk factor for colorectal cancer and other health conditions, interventions to increase 
the engagement of individuals who are obese are needed. Weight loss is one health behavior that 
is important to consider when assessing health outcomes.  
1.3.2 Tobacco Cessation 
Another health behavior that contributes to poor health, tobacco usage, is one of the most 
significant causes of cancer-related morbidity and mortality in the United States.28 In 2015, around 
15.1% of adults in the nation were current smokers.28 Tobacco usage has been associated with a 
variety of health risks, including cancer.29 The American Cancer Society estimated that in 2017, 
around 32% of deaths caused by cancer are directly attributable to tobacco usage.29 Smoking has 
been most strongly associated with lung, oropharynx and larynx cancers, but has also been found 
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to be associated with colorectal cancer.30 After a cancer diagnosis, tobacco cessation has been 
associated with better prognosis.31 A recent meta-analysis analyzed the smoking behavior and 
survival rates of 12,414 patients recently diagnosed with colorectal cancer.31 It was found that 
compared to those who continued to smoke, smoking cessation was associated with both increased 
overall and colorectal cancer-specific survival rates. Quitting tobacco usage may reduce the 
associated risk of developing colorectal cancer and the poorer prognosis. 
Tobacco status has not only been associated with health outcomes; it has also been related 
to patient engagement. A study that analyzed health care providers’ counseling regarding smoking 
cessation sampled a total of 8,656 participants who were autoworkers and their spouses through a 
mail survey.6 As the autoworkers all received similar health benefits through union rules, the 
differences in health benefits were largely controlled for. Current levels of patient engagement 
were measured through a 4-question survey asking how many times participants engaged in 
specific behaviors during a clinical encounter. Provider counseling on smoking cessation and 
smoking behavior questions over the past year were included in the same survey. It was found that 
patients who had higher engagement levels were 1.62 times more likely to have pursued a quit 
attempt over the previous year compared to those with lower engagement levels.6 Additionally, 
current smokers who had higher engagement levels were 1.51 times more likely to receive 
counseling on smoking cessation from their health care providers compared to those with lower 
engagement levels.6 It can be hypothesized that individuals who smoke and have higher 
engagement scores may be more likely to attempt to quit smoking compared to individuals who 
smoke and have lower engagement scores. 
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1.4 CANCER  
1.4.1 Prevalence of cancer and health care costs 
The growing prevalence of cancer in the United States, more than 15.5 million affected individuals, 
contributes to a large proportion of health care expenditures.29 In 2014, it was estimated that $87.8 
billion was spent on treating cancer.29 While cancer is the second most common cause of death in 
the United States, it has been estimated that around two-thirds of cancer diagnoses could be 
prevented through health behavior modifications.29 National guidelines have been established by 
health organizations, such as American Cancer Society, US Department of Health and Human 
Services, and the World Research Fund that detail recommendations on weight management, 
nutrition, and physical activity in order to decrease overall cancer incidence.32-34 A prospective 
cohort study conducted by Kabat et al. (2015) analyzed the association between following the ACS 
lifestyle guidelines and the reduction of the incidence of cancer. A total of 476,396 participants 
enrolled in the NIH-AARP Diet and Health Study were followed for a median of 10.5 years.35 It 
was found that compliance with the lifestyle guidelines was associated with an overall reduction 
of new cancer diagnoses by 10% in men and 19% in women and a reduction of new colorectal 
cancer diagnoses by 48% in men and by 35% in women.35 Designing interventions to encourage 
behavior modification that, as a result could prevent cancer from developing, could reduce the 
incidence and mortality of cancer as well as save substantial health care dollars. 
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1.4.2 Hereditary Predispositions to Cancer 
Hereditary predispositions to cancer are associated with increased chances to develop certain 
cancers over a person’s lifetime. Two of the more common hereditary cancer syndromes include 
Lynch syndrome (caused by mutations in the MSH1, MSH2, MSH6, PMS2, and EPCAM genes) 
and Hereditary Breast and Ovarian Cancer syndrome (caused by mutations in the BRCA1 and 
BRCA2 genes). Lynch syndrome increases the risk of colorectal cancer as well as uterine, stomach, 
ovarian, small bowel, urinary tract, pancreatic, and brain cancers.36 Individuals with mutations in 
the Lynch syndrome-associated genes have a 10-82% chance to develop colon cancer over their 
lifetime, compared to the general population risk of 4.5%.36 Hereditary Breast and Ovarian Cancer 
syndrome increases the risk of breast, ovarian, prostate, and pancreatic cancers, and melanoma.37 
Women with mutations in BRCA1 or BRCA2 genes have a 40-80% chance to develop breast 
cancer and a 11-24% chance to develop ovarian cancer over their lifetime.37  
1.4.3 Behavioral modifications and Hereditary Predispositions to Cancer  
Risk modifying factors have been suggested to decrease the likelihood of cancer development, 
even in individuals with hereditary cancer syndromes.38,39 A previous study found that in 
individuals with Lynch syndrome, those with higher physical activity levels had lower chances of 
developing breast cancer.40 Both body weight and smoking have also been reported to contribute 
to cancer development in patients with hereditary cancer syndromes.41,42 Kotsopoulos et al. (2005) 
performed a matched case-control study of 1,073 pairs of women to assess if changes in body 
weight were associated with the risk of developing breast cancer in individuals with mutations in 
the BRCA1 and BRCA2 genes. It was concluded that women who lost 10 pounds or more between 
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ages 18 and 30 were 0.47 times significantly less likely to develop breast cancer compared to 
controls, which translates to a 34% decrease in the risk of developing breast cancer. Another study 
analyzed the effect of smoking on breast cancer risk on a matched case-control population that 
included 2,538 women with mutations in the BRCA1 and BRCA2 genes.43 It was found that being 
a former smoker was significantly associated with a 1.27% increased risk of developing breast 
cancer among individuals with mutation in the BRCA1 gene. However, no significant risk was 
observed among current smokers with mutations in the BRCA1 and BRCA2 genes. Similarly, 
Watson et al. (2004) performed a retrospective cohort study utilizing data from the Hereditary 
Cancer Institute at Creighton University’s registry to assess if tobacco use was associated with risk 
of developing colorectal cancer in individuals with mutations in the MLH1 or MLH2 genes. The 
authors reported that those who were smokers were 1.43 times significantly more likely to develop 
colorectal cancer compared to those who did not smoke.42 The two aforementioned studies 
demonstrate that behavioral modifications have the power to reduce the cancer risks associated 
with inherited cancer syndromes.  
1.4.4 Health Behavior Models  
While behavioral modification can reduce cancer risks, understanding the motivation to pursue 
behavior changes can help determine interventions. The application of two different psychological 
theories may explain the behaviors of individuals with positive genetic testing results. The first 
theory, the Health Belief Model, incorporates the effect of beliefs and perceptions on an 
individual’s ultimate decision on whether or not to adopt a health behavior change (Figure 1).44 
The model specifically addresses perceived susceptibility, perceived severity, perceived benefits, 
perceived barriers, cues to action, and self-efficacy. A previous study analyzed the association 
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between an adaptation of the health belief model and the likelihood of pursuing genetic testing for 
hereditary cancer.45 The authors found that perceived benefits, perceived barriers, perceived 
susceptibility, and pessimism of undergoing genetic testing all impacted an individual’s decision 
to pursue testing after accounting for contributing factors such as age, socioeconomic status, and 
family history of cancer. The application of the Health Belief Model to behavior change after 
genetic testing may conclude that those who have a genetic mutation that places them at higher 
risk for cancer might view the information as motivation to pursue healthier lifestyle factors to 
decrease their risk. It is hypothesized that an individual’s perception of their susceptibility to 
cancer, perception of severity of a cancer diagnosis, as well as perceived benefits of losing weight 
or quitting smoking would influence a person’s decision to pursue the behavior change. The Health 
Belief model is one model that might explain an individual’s likelihood to adopt change. 
 
Figure 1. Health Belief Model  
(adapted from Glanz et al. 2008)46 
 
A second theory, the Health Locus of Control, addresses an individual’s perception of the 
extent to which their health is controlled by their own actions or by outside actions.47 A previous 
study assessed whether or not an individual’s health locus of control was associated with the 
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likelihood to participate in breast cancer screening.48 A total of 461 unaffected women who had a 
family history of cancer were included in the study. Individuals who had a higher internal locus of 
control were significantly more likely to perform self-breast exams but the locus of control scores 
were not associated with likelihood of receiving mammograms.48 In the current study, it is 
hypothesized that if an individual has a higher external locus of control, then he/she might believe 
that genetic testing results equate to the development of cancer. Therefore, individuals might not 
think that a behavioral change will positively affect them. Understanding an individual’s 
perceptions and motivations may help predict their health outcomes.48  
1.4.5 Impact of Genetic Information on Behavior Change 
While understanding the different theories that address behavior change is important, direct 
measurements of outcomes after receiving genetic information may further elucidate the likelihood 
of behavior change. A previous study analyzed the responses after individuals received genetic 
susceptibility information by mail in a population of 199 individuals aged 25-40 years old.49 After 
3-months, it was found that only 1% of participants had discussed their results with a health care 
provider.49 A few studies have assessed beliefs towards and compliance with screening and 
lifestyle recommendations in patients with hereditary diseases. For individuals with Lynch 
syndrome, there is around a 95.9% compliance rate for receiving the recommended 
colonoscopies.50 However, it is unclear if this high compliance with cancer screening 
recommendations is comparable to a compliance with lifestyle recommendations, such as being 
physically fit or eating a healthy diet.  Palmquist et al. (2011) investigated the beliefs regarding 
the relationship between diet and cancer prevention in patients at risk for Lynch syndrome. A total 
of 390 individuals first completed a questionnaire to measure their perceptions on diet and cancer 
17 
and then underwent genetic counseling. The authors found that 83% of the participants believed 
that a healthy diet could lead to cancer prevention.51 The belief was strongest when an individual 
had a previous cancer diagnosis, a high perceived controllability, and a high level of genetics 
knowledge. 51 The strong belief in the ability of lifestyle factors to prevent cancer may translate to 
a high compliance rate with positive lifestyle behaviors, but more research is needed to draw 
further conclusions. 
While previous studies have reported high compliance rates for cancer screening 
recommendations, studies regarding compliance with lifestyle recommendations in patients with 
hereditary diseases have been mixed.50,52,53,54,55 A study by Ruffin et al. (2011) conducted a cluster-
randomized clinical trial to investigate the effect of delivering personalized risk messages to 
individuals with a strong family history of diseases, including breast and colorectal cancers, on 
health behavior changes. A total of 3,344 participants were divided into an intervention group and 
a control group. The intervention group engaged with Family Healthware, which is a web-based 
tool designed to deliver personalized risk messages based on family history. The control group 
received age- and sex- related health messages. The authors found that participants who received 
the risk messages based on family history were significantly more likely to positively change their 
eating habits as well as increase their physical activity compared to those who received age- and 
sex-related messages.52 The positive impact of delivering personalized risk information is 
consistent with other studies that have directly measured the effect of delivering genetic testing 
results.52,56 
A study by Chao et al. (2008) assessed health behavior changes of individuals after 
undergoing genetic counseling for Alzheimer disease.56 The randomized controlled trial recruited 
162 participants at risk for Alzheimer disease. One year after receiving their results, participants 
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were asked three health behavior questions related to diet, exercise, and medication. It was found 
that participants who learned they had the APOE ε4 allele, placing them at higher risk for 
Alzheimer disease, were significantly more likely to pursue risk-reducing health behavior changes 
one year after receiving genetic counseling compared to those who did not have the ε4 allele.56 
Receiving positive genetic test results might make an individual more likely to pursue heath 
behavior changes than receiving negative results will. 
Another study assessed the relationship between genetic testing for alpha-1 antitrypsin 
deficiency and changes in smoking behavior.53 Alpha-1 antitrypsin deficiency is a genetic 
condition that increases susceptibility to lung disease, COPD, and emphysema. This susceptibility 
is further exacerbated when individuals are exposed to cigarette smoke. Participants who were 
found to be affected received informational pamphlets and the majority underwent phone 
counseling as well. The authors of the study concluded that those who were discovered to have 
severe alpha-1 antitrypsin deficiency were 3.3 times more likely to engage in quit attempts, were 
more likely to pursue treatment options (such as pharmacotherapy and smoking cessation 
programs, and nicotine replacement) and reported decreased smoking rates after 3 months 
compared to those who were carriers and those who were unaffected. However, the authors did 
not find any significant results related to abstinent levels after three months, which highlights the 
complexity of smoking cessation. These results lead to the conclusion that genetic testing may 
have an impact on smoking reduction but not total abstinence. While some studies conclude that 
knowledge of increased health susceptibility does positively impact behavior change, other studies 
have found the opposite or no impact.   
A study investigated the impact of receiving genetic testing results for Lynch syndrome on 
smoking behaviors and rates of receiving colonoscopies over a 5-year period.57 It was found that 
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those who discovered they had a pathogenic variant in the Lynch syndrome-associated genes and 
who had never been diagnosed with cancer were 13.124 times more likely to receive colonoscopies 
compared to those who elected to not receive their genetic results but who also had positive genetic 
testing (pathogenic variants).57 It was also found that individuals who did not have a genetic 
mutation and who had never been diagnosed with cancer were 1.213 times less likely to quit 
smoking compared to those who did not receive their genetic testing results but who also had 
negative genetic testing.57 Additionally, a meta-analysis of 18 studies was conducted by Hollands 
et al. (2016) and examined the impact of communicating tailored genetic risks on an individual’s 
incentive to pursue lifestyle changes that have the potential to reduce disease risk.54 Genetic 
information assessed in the studies included mutations associated with diseases such as cardiac 
conditions, cancers, diabetes, and Alzheimer’s disease. It was found that the genetic information 
did not have an impact on motivation to pursue risk-modifying behaviors, including smoking 
cessation and physical activity.54 The authors concluded that genetic testing as an intervention to 
change health behaviors would not be an effective public health approach. These findings are 
consistent with a study by Bloss, Schork & Topol (2011) that assessed outcomes of receiving a 
genomewide risk scan. A total of 2,037 participants were recruited from health and technology 
companies to partake in the study. The authors reported that the communication of direct-to-
consumer genome-wide testing results that indicated increased risks for disease were not 
associated with behavior change including changes in exercise habits, dietary fat consumption, 
and anxiety.55 However, not all of the participants in both studies received genetic counseling. 
Given the mixed results regarding adherence to lifestyle recommendations, further research into 
factors related to health behavior changes would be beneficial.   
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1.5 GENETIC COUNSELING 
1.5.1 Genetic Counseling Practice 
The epidemiological goal of genetic services is to decrease the burden of genetic diseases on a 
population.58 Genetic counseling services include providing education, psychosocial support, 
resources, and testing options. Genetic counselors aim to help individuals with possible genetic 
predispositions manage their risks for developing or passing on a genetic disorder. The National 
Society of Genetic Counselors defines genetic counseling as follows:  
“Genetic counseling is the process of helping people understand and adapt to the medical, 
psychological and familial implications of genetic contributions to disease. This process 
integrates the following: 
• Interpretation of family and medical histories to assess the chance of disease 
occurrence or recurrence. 
• Education about inheritance, testing, management, prevention, resources and 
research. 
• Counseling to promote informed choices and adaptation to the risk or condition.” 
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 Genetic counselors serve to guide decision making and, rather than specifically recommend 
courses of action, work with patients to help determine the best individualized course of action. 
As part of the shared-decision making model, genetic counselors often educate clients on the 
national recommended guidelines set forth by organizations such as the American Cancer 
Society.32 Additionally, in a genetic counseling session beneficial lifestyle changes are also often 
discussed in the context of reducing an individual’s risk of developing cancer.7 While genetic 
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counselors provide unique services, understanding health-related outcomes of genetic counseling 
is an important consideration in the practice.  
1.5.2 Impact of Genetic Counseling 
Genetic counselors have a unique skillset that encompasses genetics expertise, education, 
psychosocial support, patient advocacy, and resource identification. However, there has been 
limited research related to specific evidence-based patient outcomes of genetic counseling.7,8 To 
address this lack of research, Redlinger-Grosse et al. (2015) sought to identify an all-encompassing 
list of the beneficial outcomes of genetic counseling services utilizing the Reciprocal-Engagement 
Model (REM) as a practice model for genetic counseling.7 The REM is comprised of five tenants 
and 17 patient-centered goals of genetic counseling. In the study, five focus groups, comprised of 
27 peer-nominated leaders in the genetic counseling field, identified 194 genetic counseling 
outcomes related to the REM. The authors identified four major outcomes of genetic counseling− 
patient knowledge, decision-making, patient satisfaction, and psychological adaptation− which all 
relate to engagement. One identified goal, “a change in patient’s adherence to health behaviors”, 
directly relates to the aim of this paper. Since the outcomes identified by Redlinger-Grosse et al. 
(2015) were provider reported, further research is needed to establish evidence-based patient 
outcomes in order to gain knowledge on the clinical effectiveness of genetic counseling. 
Several studies have directly measured outcomes related to genetic counseling. Bowen et 
al. (2004) performed a randomized controlled trial to assess outcomes of breast cancer risk 
counseling.9 A total of 354 asymptomatic participants were recruited and were randomly assigned 
to either receive an individual genetic counseling session, a psychosocial group counseling session, 
or a control group. It was found that individuals in both counseling groups experienced decreased 
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cancer-related worry and decreased perceived risks compared to the control group.9 Similarly, 
Inglis et al. (2014) evaluated patient outcomes after undergoing psychiatric genetic counseling.60 
A total of 75 clients consented to participate. All participants completed the GC outcomes scale 
(GCOS), a validated survey that measures patient empowerment, and participants with mental 
illness completed the GCOS and the Illness Management Self Efficacy scale (IMSES) prior to 
genetic counseling and at a 1-month follow-up appointment. Paired sample t-tests were utilized to 
assess changes in pre- and post-genetic counseling outcome measurements. It was found that both 
mean GCOS, which measured empowerment, (p < 0.0001) and IMSES scores, which measured 
self-efficacy, (p = 0.011) significantly increased after genetic counseling.60 These studies provide 
evidence that genetic counseling is associated with positive outcomes.  
Athens et al. (2017) conducted a review of 58 Randomized Control Trials evaluating 
patient outcomes across four genetic counseling specialties: Cancer (n = 45), Prenatal (n = 7), 
Adult (n = 5), and Pediatrics (n = 1).8 Of the reported patient benefits, 40 studies (69%) identified 
psychological well-being, 29 studies (50%) identified knowledge, 23 studies (40%) identified 
perceived risk, 20 studies (35%) identified satisfaction, 15 studies (26%) identified intentions to 
pursue genetic testing/screening, 11 studies (19%)  identified genetic testing uptake, 10 studies 
(17%) identified decision quality, nine studies (16%) identified medical management/health 
behavior, five studies (9%) identified sharing information, and two studies (5%) identified 
informed choice.8 The majority of the identified patient outcomes will presumably increase patient 
engagement, as having more knowledge about health, satisfaction with health care experiences, 
and involvement with the health care system have all been found to be behaviors related to active 
participation in one’s health.1 However, no studies reported an actual change in behavior of 
patients after receiving genetic services, aside from pursuing the management recommendations 
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in hereditary cancer syndromes. In order to measure the goal of achieving “a change in patient’s 
adherence to health behaviors” as identified by Redlinger-Grosssought et al. (2015), additional 
research on specific changes in health behaviors after genetic counseling will address the gap in 
the current research.7   
1.6 PREVIOUS PILOT STUDY 
This study serves to expand upon a previous pilot study that found patient engagement (measured 
with the ACE measure) increased after a genetic counseling visit in a hereditary gastrointestinal 
(GI) tumor clinic.61 During the genetic counseling session, patients received education regarding 
cancer and genetics and were provided with a risk assessment of the likelihood of hereditary 
predisposition to cancer based on their personal medical history and family history. The patient 
population for the lifestyle behavior analysis included six participants who were current smokers 
and seven participants who were currently overweight at the time of their initial appointment. The 
pilot study found that individuals with a higher ACE score were more likely to undergo lifestyle 
behavior changes after receiving genetic counseling.61 The results were stronger when considering 
baseline ACE scores (mean difference of 4.7 points) compared to post-counseling ACE scores 
(mean difference of 1.9 points); therefore, indicating that baseline ACE scores may be more 
indicative of health behavior changes.61 Based on the results of the pilot study, it can be 
hypothesized that baseline ACE scores is a better predictor of behavior change than post-
counseling ACE scores. It was also found that those who had a family history of cancer were more 
successful in lifestyle changes (83% success rate) compared to those who had a recent diagnosis 
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of cancer (17% success rate). Further research can help to identify effective interventions for 
lifestyle behavioral changes in order to reduce individual cancer risk. 
To date, no other studies have investigated the impact of genetic information on 
engagement and modifiable lifestyle factors of high-risk cancer patients. This research can serve 
to help identify effective public health interventions that can be integrated into a clinical setting, 
such as administering the ACE survey to measure a patient’s engagement before their appointment. 
Through identifying individuals who have a low engagement in their health, genetic counselors 
could use that information to identify individuals at risk for poor health outcomes and to further 
personalize the session. Ultimately, these findings have the potential to improve public health and 
may lead to lower healthcare costs.  
1.7 STUDY AIMS  
The specific aims and hypotheses of this study include: 
Aim 1: To investigate the impact of an individual’s baseline engagement in their health, as 
measured by the Altarum Consumer Engagement (ACE Measure), on lifestyle behavior 
outcomes for tobacco cessation and weight loss before and after genetic counseling.  
Hypothesis: Individuals who have higher engagement scores will be more likely 
to change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals who have lower engagement scores.  
Aim 2: To compare engagement and behavioral changes between individuals with a 
pathogenic variant those with no pathogenic variant. 
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Hypothesis 1: Individuals who have a pathogenic variant will be more likely to 
change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals who have no pathogenic variant.   
Hypothesis 2: Individuals who have a pathogenic variant will have increased 
engagement scores after a genetic counseling session compared to individuals who 
have no pathogenic variant.   
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 MANUSCRIPT 
2.1 INTRODUCTION 
With the growing complexity of the health care system, greater demands are now being placed 
on patients to navigate, access, and understand health care. A new field of study, called patient 
engagement, has arisen to understand the implications of being involved in one’s health care. 
The term patient engagement was defined by Gruman et al. (2010) as “actions individuals must 
take to obtain the greatest benefit from the health care services available to them.”1 Research has 
found that more highly engaged patients were significantly less likely to be obese, to smoke, and 
to have an emergency department visit or a hospital stay within the past 12 months.2 Further, 
patients with lower engagement levels had health care costs that were up to eight times greater 
than those with the higher engagement levels.3 Measuring levels of engagement among patients 
may provide key information on outcomes that can be integrated into the clinic and reduce 
healthcare costs.  
Given the recent information on the association between patient engagement, health 
outcomes, and healthcare costs, more health care providers may be interested in measuring the 
engagement levels of their patients. Only a small number of validated engagement measures exist, 
and most do not measure multiple factors of patient engagement. The Altarum Consumer 
Engagement (ACE) Measure™ (June 2015) is one such validated patient measure created to 
provide a more comprehensive, up-to-date measurement of a patient’s engagement in their health 
(Appendix A.1).15 The ACE measure utilized Gruman’s patient engagement definition in order to 
address all of the factors of engagement. The tool has three domains, which are defined as: 
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• “Commitment: confidence and ability to maintain a healthy lifestyle and manage 
one’s health. 
• Navigation: confidence and ability to ask about and participate in treatment 
decisions. 
• Informed Choice: Informed patterns of seeking and using information about health 
and healthcare.”15 
This measure has previously been found to be associated with health outcomes.16 A current 
study that utilized the ACE measure assessed engagement levels in a population of patients with 
diabetes and showed that the Commitment domain levels were associated with changes in glycated 
hemoglobin (HbA1c) levels.16 Those who had higher Commitment scores were more likely to have 
improved HbA1c levels after an 8-month period compared to those with lower Commitment 
scores.16 Clinicians could utilize this information to target interventions towards those with lower 
Commitment scores. Therefore, the ACE measure has the potential to be integrated into a clinical 
setting in order to improve patient care.  
Several behavior-related factors that may be, in part, influenced by patient engagement 
have been studied extensively. Being obese has been found to be related to poorer engagement; 
individuals who were obese were 25-40% less likely to receive colorectal screening compared to 
those who were not obese.4,5 Therefore, if individuals are successful in weight loss, then they may 
become more likely to engage in behaviors such as receiving cancer screening that will contribute 
to their health. Another health behavior that contributes to poor health, tobacco status, has also 
been related to patient engagement. It was found that patients who had higher current levels of 
engagement were 1.62 times more likely to have pursued a tobacco quit attempt over the past year 
compared to those with lower engagement levels.6 It can be hypothesized that individuals who 
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smoke and have higher engagement scores may be more likely to attempt to quit smoking 
compared to individuals who smoke and have lower engagement scores. 
Health behaviors are just one of the many areas that have been implicated with patient 
engagement. Genetic counseling is another field that is directly related to patient engagement.7 
Genetic counselors have a unique skillset that encompasses genetics expertise, education, 
psychosocial support, patient advocacy, and resource identification. While behavioral risk factors 
like patient weight and tobacco status may not be the focus of many genetic counseling sessions, 
prior research has shown that these factors may increase the risk for cancer in individuals with 
hereditary cancer syndromes.38,39 Furthermore, genetic counseling has previously been found to 
be associated with increased self-efficacy and empowerment in patients, as well as decreasing 
cancer-related worry and perceived risk.9,60 Given the importance of these environmental factors 
in cancer risk and the ability of genetic counseling to improve elements related to patient 
engagement, the relationship between receiving genetic information and subsequent health 
behavior changes is important to consider in a clinical setting. Previous literature assessing health 
behavior changes of an individual after receiving genetic testing results have been mixed. One 
study found that participants who learned they had the APOE ε4 allele, placing them at higher risk 
for Alzheimer disease, were significantly more likely to pursue risk-reducing health behavior 
changes one year after receiving genetic counseling compared to those who did not have the ε4 
allele.56 Similarly, another study found that patients who were discovered to have severe alpha-1 
antitrypsin deficiency were 3.3 times more likely to engage in tobacco quit attempts, were more 
likely to pursue treatment options and reported decreased smoking rates after 3 months compared 
to those who were carriers and those who were unaffected.53 However, the authors did not find 
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any significant results related to tobacco abstinent levels after three months, which highlights the 
complexity of smoking cessation.  
While the aforementioned studies conclude that knowledge of increased health 
susceptibility due to a genetic risk does impact behavior change, other studies have found the 
opposite. A meta-analysis of 18 studies conducted by Hollands et al. (2016) found that genetic 
information (mutations associated with diseases such as cardiac conditions, cancers, diabetes, and 
Alzheimer’s disease) did not have an impact on motivation to pursue risk-modifying behaviors, 
including smoking cessation and physical activity.54 The authors concluded that genetic testing as 
an intervention to change health behaviors would not be an effective public health approach. These 
findings are consistent with a study by Bloss, Schork & Topol (2011) that reported that the 
communication of direct-to-consumer genome-wide testing results that indicated increased risks 
for disease were not associated with behavior modifications including changes in exercise habits, 
dietary fat consumption, and anxiety.55 However, not all of the participants in both studies 
underwent genetic counseling and the participants did not always receive risk information that 
would significantly increase their risk of disease. Given the mixed results regarding adherence to 
lifestyle recommendations, further research into the influence of genetic counseling and genetic 
test results on health behavior changes would be beneficial.   
This study serves to expand upon a previous pilot study that found that patient engagement 
(measured with the ACE measure) increased after a genetic counseling visit in a hereditary 
gastroenterology clinic.61 During the genetic counseling session, patients received education 
regarding cancer and genetics and were provided with a risk assessment of the likelihood of a 
hereditary predisposition to cancer based on their personal medical and family history. The patient 
population for the lifestyle behavior analysis included six participants who were current smokers 
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and seven participants who were currently overweight at the time of their initial appointment. The 
pilot study found that individuals with a higher ACE score were more likely to undergo lifestyle 
behavior changes after receiving genetic counseling.61 The results of the pilot study were stronger 
when considering baseline ACE scores (mean difference of 4.7 points) compared to post-
counseling ACE scores (mean difference of 1.9 points); suggesting that baseline ACE scores may 
be more indicative of health behavior changes.61 It was also found that those who had a family 
history of cancer were more successful in lifestyle changes (83% success rate) compared to those 
who had a recent diagnosis of cancer (17% success rate). Further research can help to identify 
effective interventions for lifestyle behavioral changes in order to reduce individual cancer risk. 
To date, no other studies have investigated the impact of genetic information on 
engagement and modifiable lifestyle factors of high-risk cancer patients. This research can serve 
to help identify effective public health interventions that can be integrated into a clinical setting, 
such as administering the ACE survey to measure a patient’s engagement before their appointment. 
Genetic counselors could use this information to identify individuals at risk for poor health 
outcomes and to further personalize the session. Ultimately, these findings have the potential to 
improve genetic counseling practice, and public health, and may lead to lower healthcare costs.  
The following were the specific aims and hypotheses of the study: 
Aim 1: To investigate the impact of an individual’s baseline engagement in their health, as 
measured by the Altarum Consumer Engagement (ACE Measure), on lifestyle behavior 
outcomes for tobacco cessation and weight loss before and after genetic counseling.  
Hypothesis: Individuals who have higher engagement scores will be more likely 
to change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals who have lower engagement scores.  
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Aim 2: To compare engagement and behavioral changes between individuals with a 
pathogenic variant versus those with no pathogenic variant. 
Hypothesis 1: Individuals who have a pathogenic variant will be more likely to 
change their behavior (lose weight or stop smoking) after a genetic counseling 
session compared to individuals with no pathogenic variant.   
Hypothesis 2: Individuals who have a pathogenic variant will have increased 
engagement scores after a genetic counseling session compared to individuals with 
no pathogenic variant. 
2.2 METHODS 
2.2.1 Participants 
Participants were recruited from the University of Pittsburgh Medical Center (UPMC) Hereditary 
GI Tumor Program’s patient population who received an initial genetic counseling session from 
July, 2016 to December, 2017. Those who were under the age of 18 or unable to give informed 
consent were excluded from the study. Patients were referred to the program due to a personal 
history and/or a family history that was suggestive for a hereditary predisposition to cancer. 
Indications for referral include young ages of cancer diagnoses, multiple primary cancer diagnoses, 
multiple family members affected with the same or related types of cancers, and/or tumor studies 
indicative of a possible underlying genetic cause.  
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2.2.2 Procedure 
This study was approved by the University of Pittsburgh IRB (PRO16050209, 07/12/16) 
(Appendix A.6). The investigators obtained informed consent for participants who met the study 
criteria and who were interested in participating in the study. Next, the Altarum Consumer 
Engagement (ACE) Measure was delivered verbally to assess individual healthcare engagement.15 
The ACE measure is comprised of 12 statements and utilizes a 5-point Likert scale, ranging from 
“strongly disagree” to “strongly agree” (Appendix A.1).15 It has three different domains, 
Commitment, Navigation, and Informed Choice, with four questions comprising each domain.15 
An average of the four questions per domain was taken and then multiplied by 6.25 to produce a 
total score for each domain ranging from 0-25.15 The final scores for each domain were then 
summed to calculate an individual’s total engagement score ranging from 0-75.15 
After completing the survey, the participants next received genetic counseling and a 
consult with a gastroenterologist who specializes in hereditary GI cancer syndromes. Patients 
insured by UPMC Health Plan who were overweight (BMI ≥ 30) or were current smokers were 
given standard lifestyle modification reading material, as well as a Prescription for Wellness to a 
tobacco cessation or weight loss health coaching program if they were interested. When 
participants were both overweight and current smokers, the gastroenterologist and patient 
discussed which program would be most beneficial. Patients who were overweight or used 
tobacco and had a different insurer were given only the standard of care reading material for 
lifestyle changes.    
The Prescription for Wellness is a model of health coaching that is physician-prescribed 
and is available at no cost to any patient insured by UPMC Health Plan. In the current study, once 
a prescription was given by the gastroenterologist, the patient either called the program, or a health 
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coach contacted the participant. The program consisted of 6-8 weekly phone calls conducted by 
health coaches. Sessions addressed the overall goals and concerns for the patient, as well as 
explored motivations to pursue health behavior changes. Other support resources, such as assigned 
homework or referrals to other services were also given when appropriate.  
The genetic counseling that participants received consisted of a review of cancer and 
genetics, a personalized cancer and genetic risk assessment, information about hereditary cancer 
syndromes, cancer preventive measures and psychosocial counseling. When clinically appropriate, 
genetic testing was discussed and offered. Participants who had genetic testing received the results 
from a genetic counselor by telephone within a three-month time period after their initial 
appointment. Possible results included positive (pathogenic or likely pathogenic variant), a variant 
of unknown significance (VUS) and negative (benign or likely benign variant). All participants 
were then contacted via phone three to five months after their initial office appointment to repeat 
the ACE measure survey. Individuals who were overweight (BMI ≥ 30) and individuals who were 
current tobacco users at the time of their initial visit were also asked to complete the Lifestyle 
Questionnaires, either the weight loss questionnaire or the smoking cessation questionnaire, as 
appropriate, during the post follow up phone call (Figure 2).  
 
Figure 2. Protocol Flowsheet 
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2.2.3 Data Analysis 
Pre- and post- visit ACE scores were first tested for normality of distribution across individual 
domains and total engagement scores. To corroborate the previous pilot study, paired sample t-
tests were conducted to analyze differences in engagement scores across all participants 
excluding those who were included in the previous pilot study. In order to analyze the effect of 
pre-engagement levels on weight loss, univariate and multiple linear regressions to adjust for 
age, gender, cancer status, and completion status of the Prescription for Wellness were 
conducted. Paired sample t-tests and multiple logistic regressions were also conducted in order to 
analyze the effect of pre-engagement levels on smoking cessation. For the variant status analysis, 
variant of unknown significance and negative results were combined together since participants 
were told both in pre-counseling and post-counseling that variants of unknown significant (VUS) 
results should be treated as negative results. Univariate and multiple linear regressions were 
conducted to test the associations of both changes in engagement scores and weight loss with 
genetic variant status. Fisher’s exact test was computed to test the association of smoking 
cessation and genetic mutation status. The statistical software STATA (StataCorp 2015) was 
used for analyses. Two indicators of weight loss were considered in the analysis: quantitative 
percent change in BMI (∆BMI) and categorical successful weight loss (SWL)/failure to lose 
weight, with success defined as a 3-month difference of ≥ 2.5% body weight, 4-month difference 
of ≥ 3.25% body weight, or 5-month difference of ≥ 4% body weight. Previous literature has 
concluded that weight loss ranging from 2.5-5% and above is associated with a reduction in 
obesity-related health risks.62 Smoking cessation definitions were adapted from Velicer et al. 
(2002); total smoking cessation was defined as not smoking for 30 days and a quit attempt was 
defined as not smoking for 7 days.63 Individuals who were undergoing cancer treatment during 
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the time of the study were excluded in the health behavior analyses, as active cancer treatment 
might reduce the likelihood that an individual could pursue health behavior changes.  
In order to carry out the weight loss analyses, participants were divided into different 
categories. The different categories included: 
• Participants who were not eligible for the Prescription for Wellness compared to 
participants who were eligible for the Prescription for Wellness  
• Eligible participants who did not accept the referral from the physician compared 
to participants who accepted the referral from the physician,  
• Participants given a Prescription for Wellness who did not complete the health 
coaching program compared to participants who completed the health coaching 
program (Figure 3). 
 
 
Figure 3. Health Behavior Participant Categories 
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2.3 RESULTS 
Two hundred and thirty-four (234) participants initially consented to be in the study. Of these, two 
participants elected to withdraw from the study when they were contacted to complete the follow-
up ACE survey, thirty-one (31) participants were lost to follow up, three participants passed away 
during the study, and three participants were excluded due to failing to answer at least two 
questions in either the pre- or post- ACE survey. A total of 195 participants aged 18-86 years old 
(mean age of 52 years) were included in the analysis (Table 1). Majority of participants were 
Caucasians (97%) and female (62%). Almost half (47%) of participants had no personal cancer 
history, and the most common cancer type was colorectal (32%). Thirteen participants completed 
a health coaching program, the Prescription for Wellness program, aimed at weight loss (n = 10) 
or smoking cessation (n = 3) during the study. Of the 195 participants, data from sixty-two 
participants had been analyzed by the previous pilot study.  
Table 1. Characteristics of the sample at baseline 
 n % 
Sex   
Female 121 62 
Male 74 38 
Age   
18-34 32 16 
35-51 58 30 
52-64   57    29 
65 or older 48 25 
Mean age = 52   
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Ethnicity   
Caucasian 189 97 
African American 6 3 
Cancer History   
No cancer 95 47 
Colorectal 58 32 
Pancreatic 8 4 
Other cancer 34 14 
Total 195           100 
 
Sixty-one participants had a BMI ≥ 30 at the time of their initial appointment. Of the total 
61 participants, ten participants were undergoing current cancer treatment and were excluded from 
the overall cohort. Rates of successful weight loss (SWL) (i.e., 3-month difference of ≥ 2.5% body 
weight, 4-month difference of ≥ 3.25% body weight, or a 5-month difference of ≥ 4% body weight) 
across Prescription for Wellness categories is summarized in Figure 4. Participants were then 
divided into categories based on eligibility, acceptance, and completion status of Prescription for 
Wellness (Figure 4). Overall, 31% of individuals who received genetic counseling lost weight. 
Individuals with UPMC Health Plan who were eligible for referral, individuals who accepted the 
referral, and individuals who completed the program were all more likely to lose weight than their 
counterparts. For individuals in this study who completed the Prescription for Wellness program 
demonstrated a 60% weight loss rate, which can be compared to a previous report of individuals 
who enrolled in the Prescription for Wellness who did not receive genetic counseling demonstrated 
a 43.9% weight loss rate.64  
Table 1 Continued 
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Figure 4. Results of SWL for the Weight Loss Participant Categories 
 
 
Eighteen participants were current smokers at the time of their initial appointment. Of the 
18 participants, three were undergoing current cancer treatment and were excluded from the 
smoking cessation analysis cohort. Among the remaining 15 participants, 20% of individuals quit 
smoking and 47% engaged in a quit attempt (Figure 5). Individuals with UPMC Health Plan who 
were eligible for referral and individuals who accepted the referral were more likely to quit 
smoking or pursue a quit attempt compared than their counterparts. Among those who accepted 
the referral, the smoking cessation rates among those who completed the program and those who 
did not complete the program were equivalent—33% quit smoking and 67% engaged in quit 
attempt. 
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Figure 5. Results for Smoking Cessation Participant Categories 
 
 
One hundred and forty-six participants had genetic testing; 10 participants had undergone 
genetic testing and received their results prior to their appointment, 133 individuals received the 
results prior to the delivery of the post-engagement survey, and 3 had not received their results yet 
at the time of the delivery of the post-engagement survey. Of the 133 who had received their results 
within the time period of this study, 34 (26%) had positive testing (pathogenic variants were 
detected), 14 (10%) were found to have a variant of unknown significance (VUS), and 85 (64%) 
had negative testing (no pathogenic variants were detected).  
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2.3.1 ACE Measure across all Participants 
Previously we had demonstrated in a pilot study that patient engagement increased after a genetic 
counseling visit in a hereditary gastroenterology clinic. In this study, which looked at an 
independent cohort of 120 patients, these results were replicated. Post engagement scores 
increased after a genetic counseling appointment across all participants. There was a significant 
difference in total pre- and post-counseling ACE scores (two-sided p-value: p = 0.0001) with post-
counseling ACE scores approximately 3.2 points greater than pre-counseling scores. All of the 
domains within the ACE Measure (Navigation, Commitment, and Informed Choice) also were 
significantly greater after counseling (p = 0.0038; p = 0.0012; and p = 0.0268 respectively) (Table 
2). 
Table 2. Mean Engagement Score Pre- and Post-Counseling and Differences 
Averages of Results (n = 120) 
 Pre-counseling 
ACE Score 
Post-counseling 
ACE Score 
Difference p-value 
Navigation 18.186  19.206 1.02 0.0038 
Commitment 17.247 18.347 1.099 0.0012 
Informed Choice 13.750 14.688  0.938 0.0184   
Total 49.183 52.240 3.057 0.0001 
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Figure 6. Pre-counseling ACE vs. post-counseling ACE 
 
2.3.2 Behavior Change and Baseline Engagement 
For the overall cohort, pre-counseling ACE total scores were not significantly associated with 
ΔBMI, although there was a slight trend between higher engagement levels and being less likely 
to lose weight (p = 0.213, R2 = 0.032, 95% CI = (-0.053, 0.012)) (Figure 7) (Table 3). For the 
Navigation domain, higher pre-counseling ACE scores were significantly associated with being 
less likely to lose weight (F(1,49) = 5.45, p = 0.024, R2 = 0.100, 95% CI = (-0.164, -0.012)). The 
Commitment and Informed Choice domains were not significantly associated with change in BMI 
(F(1,49) = 0.01, p = 0.923, R2 = 0.0002, 95% CI = (-0.068, 0.061; F(1,49) = 0.19, p = 0.662, R2 = 
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0.004, 95% CI = (-0.063, 0.040 respectively). A multiple linear regression was conducted to test 
the association of weight loss and pre-counseling ACE scores (both total engagement scores and 
the individual domains) while adjusting for age, gender, cancer status, and completion status the 
Prescription for Wellness (Table 3). The same results were observed in the covariate-adjusted 
models as the univariate tests. Furthermore, the same analyses were conducted to analyze if change 
in engagement scores was associated with weight loss and none of the analyses were found to be 
significant (Appendix B). 
For the specific categories of eligibility, acceptance, and completion status of Prescription 
for Wellness, the total pre-counseling ACE scores, the Commitment domain, and the Informed 
Choice domain were not significantly associated with ΔBMI in any category. For those who were 
not eligible for the Prescription for Wellness, the Navigation domain pre-counseling ACE scores 
were significantly associated with ΔBMI, with higher Navigation engagement scores being 
associated with being less likely to lose weight (F(1,17) = 8.00, p = 0.012, R2 = 0.320, 95% CI = 
(-0.184, -0.027). 
As a post-hoc analysis, weight loss was defined as a 3-month difference of ≥ 2.5% body 
weight, 4-month difference of ≥ 3.25% body weight, or a 5-month difference of ≥ 4% body weight) 
and two-sample t-tests with equal variances were conducted to predict weight loss from baseline 
engagement (ACE) scores. For the overall cohort, total pre-counseling ACE scores did not 
significantly predict weight loss (p = 0.5025, 95% CI = (-3.400, 6.843). None of the individual 
domains were found to be significant. A multiple logistic regression was conducted on the overall 
cohort, and it was found that higher pre-counseling ACE Navigation scores were significantly 
associated with a smaller change in BMI, with age being a significant covariate (OR = 0.761, p = 
0.021, 95% CI = (0.603, 0.960). When assessing the individual categories of participants, it was 
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found that for those enrolled in the Prescription for Wellness, pre-counseling ACE Navigation 
scores were significantly associated with weight loss (p= 0.044, 95% CI = (0.138, 8.456). Those 
who failed to lose weight had higher pre-counseling ACE Navigation scores.  
 
Table 3. Pre-counseling engagement (ACE) scores relationship with weight loss (% change in BMI) in the 
overall cohort 
  
Coefficient Standard 
Error 
p-value 95% Confidence 
Interval 
Univariate Analysis- 
Pre-ACE Total -0.020 0.016 0.213 -0.053, 0.012 
Pre-ACE 
Commitment 
-0.003 0.032 0.923 -0.068, 0.061 
Pre-ACE Navigation -0.088 0.038 0.024* -0.164, -0.012 
Pre-ACE Informed 
Choice 
-0.011 0.026 0.662 -0.063, 0.040 
Multivariate Analysis (including covariates of age, gender, cancer status, and completion 
status of the Prescription for Wellness)- 
Pre-ACE Total -0.018 0.016 0.281 -0.051, 0.015 
Pre-ACE 
Commitment 
-0.006 0.032    0.846  -0.069, 0.057 
 
Pre-ACE Navigation -0.010     0.038 0.012*     -0.176, -0.023 
Pre-ACE Informed 
Choice 
0.005    0.026 0.984   -0.051, 0.052 
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Figure 7. Univariate linear regression on % change in BMI as predicted by pre-engagement levels 
 
For the overall cohort, no statistical differences in pre-counseling ACE total scores were 
found between participants who ceased smoking and those who did not (p = 0.871), 95% CI =(-
24.502, 21.002) (Table 4) (Figure 8). When looking individually at each of the specific domains 
(Commitment, Navigation and Informed Choices), none were found to be significantly different 
between participants who ceased smoking and those who did not. NO statistical differences in pre-
counseling ACE total scores were found between participants who pursued a quit attempt and those 
who did not (p = 0.942, 95% CI = (-17.639, 18.886) (Table 4) (Figure 8). None of the analyses for 
the individual domains were found to be significant. Although there was not an adequate sample 
size, a multiple logistic regression was run to predict smoking cessation status from pre-
engagement (ACE) scores to adjust for the covariates of age, gender, cancer status, and completion 
status of the Prescription for Wellness program. The overall analysis was not significant.  
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Table 4. Baseline engagement (ACE) scores relationship with total smoking cessation (>31 days) 
Averages of Results (n = 15) 
 Total Cessation (n = 3) No Total Cessation (n = 12) Difference p-Value 
Navigation 16.667 17.70833 1.042 0.7853 
Commitment 16.667 13.484 3.182 0.451 
Informed Choice 14.0625 14.45313     0.391 0.9196 
Total 47.396 45.646 1.75 0.871 
 
Table 5. Baseline engagement (ACE) scores relationship with smoking quit attempt (>7 days) 
Averages of Results (n = 15) 
 Quit Attempt (n = 7) No Quit Attempt (n = 8) Difference p-Value 
Navigation 17.188 17.77344 0.586 0.8486 
Commitment 14.063 14.063     0.125 0.971 
Informed 
Choice 
14.45313 14.45313 0.167 0.9570 
Total 45.661 46.289 0.628 0.942 
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Figure 8. Smoking cessation status as predicted by pre-engagement levels, yes = successful, no = not successful 
 
As a post hoc analysis, successful weight loss and total tobacco cessation outcomes were 
combined into one category of health behavior changes. A total of 66 participants were included 
in the analysis. No statistically significant differences in pre-counseling ACE total scores were 
found between participants who successfully made health behavior changes and those who did not 
(p = 0.749), 95% CI = (44.805, 49.919) (Table 4) (Figure 9). A multiple logistic regression was 
run to test the association of health behavior change with pre-counseling (ACE) scores to adjust 
for the covariates of age, gender, cancer status, and completion status of the Prescription for 
Wellness program. The overall analysis was not significant. When looking individually at each of 
the specific domains (Commitment, Navigation and Informed Choices), none were found to be 
significant differences in pre-counseling ACE were observed between those who made behavior 
change and those who did not.  
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Figure 9. Health Behavior Change as predicted by total pre-engagement levels 
 
2.3.3 Variant Status and ACE Differences 
Variant status did not significantly predict changes in total ACE scores, (F(1,131) = 0.43, p = 
0.514, R2 = 0.003, 95% CI = (-4.502, 2.262)) (Figure 11). In addition, analyses did not reveal 
significant differences for the individual domains, although differences in Navigation ACE scores 
approached significance (F(1,131) = 3.19, p = 0.076, R2 = 0.024, 95% CI = (-2.863, 0.146)) 
(Figure 11). A multiple linear regression was subsequently conducted to predict differences in 
ACE scores from variant status to include the covariates of age, gender, cancer status, and 
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completion status of the Prescription for Wellness program. No significantly statistical differences 
were observed.   
 
Figure 10. Change in engagement scores as predicted by variant status 
2.3.4 Variant Status and Behavior Change 
Variant status did not significantly predict weight loss (percent change in BMI), F(1,44) = 0.295, 
p = 0.295, R2 = 0.025, 95% CI = (-0.317, 1.018) (Figure 11). A multiple linear regression was 
conducted to predict weight loss from variant status to include the covariates of age, gender, cancer 
status, and completion status of the Prescription for Wellness. However, this adjusted model 
included more covariates than would be recommended for the sample size. The multivariate 
analysis did not reveal significant findings. Fisher’s exact test showed no significant difference 
between total smoking cessation and genetic variant status, p = 0.152 or between quit attempt (>7 
days abstinence from smoking) and variant status, p = 0.545 (Table 6). 
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Figure 11. Percent change in BMI as predicted by variant status 
 
 
Table 6. Summary of total smoking cessation and genetic variant status data 
 Pathogenic 
Variant 
No Pathogenic Variant Total 
Total Cessation 1 7 8 
No Total Cessation 2 1 3 
Total 3 8 11 
    
Quit Attempt 1 5 6 
No Quit Attempt 2 3 5 
Total 3 8 11 
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2.4 DISCUSSION 
This study aimed to investigate the impact of an individual’s baseline engagement in their health 
on health behavior changes and aimed to compare engagement and behavioral changes between 
individuals with a pathogenic variant those with no pathogenic variant. Identifying individuals 
who are less likely to pursue health behavior changes may allow health care providers to target 
interventions that could lead to improved clinical outcomes. Clinicians could utilize patient 
engagement measures to target such interventions. Further, understanding how behavior is 
influenced by receiving genetic information that places an individual at a greater risk to develop 
cancer would also contribute to patient care through providing additional resources to those who 
need it. Another component that this study analyzed was the effect of genetic counseling on patient 
engagement scores. As there has been limited research related to specific evidence-based patient 
outcomes of genetic counseling, this research significantly contributes to the literature.7,8 
It was found that genetic counseling significantly increased engagement scores over a 3-5-
month time period. This finding validated the previous pilot study in an independent cohort. The 
total pre-counseling and post-counseling engagement scores were both lower by approximately 
1.9 to 1.4 values on the ACE domain scoring respectively, in the current study compared to the 
pilot study. The current study delivered the pre-counseling ACE survey verbally as opposed to the 
delivery method in the pilot study where participants completed the survey on their own. 
Therefore, the delivery method of the ACE measure may not affect the results. Previous research 
has found similar beneficial outcomes of genetic counseling. Inglis et al. (2014) evaluated patient 
outcomes after undergoing psychiatric genetic counseling and found empowerment and self-
efficacy significantly increased after genetic counseling.60 Genetic counseling has also previously 
been found to decrease cancer-related worry and perceived risk.9 Athens et al. (2017) conducted a 
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review of 58 Randomized Control Trials evaluating patient outcomes across four genetic 
counseling specialties: Cancer (n = 45), Prenatal (n = 7), Adult (n = 5), and Pediatrics (n = 1).8 Of 
the reported patient benefits, 40 studies (69%) identified psychological well-being, 29 studies 
(50%) identified knowledge, 23 studies (40%) identified perceived risk, 20 studies (35%) 
identified satisfaction, 15 studies (26%) identified intentions to pursue genetic testing/screening, 
11 studies (19%)  identified genetic testing uptake, 10 studies (17%) identified decision quality, 
nine studies (16%) identified medical management/health behavior, five studies (9%) identified 
sharing information, and two studies (5%) identified informed choice. The majority of the 
identified patient outcomes will presumably increase patient engagement, as having more 
knowledge about health, satisfaction with health care experiences, and involvement with the health 
care system have all been found to be behaviors related to active participation in one’s health.1 In 
the current study, it was also found that individuals who received genetic counseling as well as 
enrolled in Prescription for Wellness health coaching program lost more weight than a previous 
report of individuals who enrolled in the Prescription for Wellness who did not receive genetic 
counseling.64 Therefore, the combined interventions of genetic counseling and a health coaching 
program may lead to beneficial health outcomes.   
The first aim of this study investigated the impact of an individual’s engagement in their 
health on lifestyle behavior outcomes for tobacco cessation and weight loss. Based on the findings, 
it can be concluded that baseline total engagement scores were not significantly associated with 
behavior changes in this population. The Navigation domain demonstrated that higher pre-
counseling ACE scores were significantly associated with an individual being less likely to lose 
weight. The Navigation domain is a measure of one’s confidence level to engage in a shared-
decision model with a health care provider. The findings could be explained by an individual’s 
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comfort level with their ability to address their weight with their health care provider. These results 
differ from the previous pilot study that had demonstrated that those who were successful in 
behavior change were more likely to have higher baseline engagement scores. However, only 13 
individuals were included in the pilot study. Additionally, the current findings that demonstrated 
no relationship between behavior change and the Commitment ACE domain are inconsistent with 
the prior literature, as a study that also utilized the ACE measurement found that individuals with 
higher baseline Commitment levels were significantly more likely to have improved HbA1c levels, 
a measurement of diabetes management, after an 8-month period compared to those with lower 
Commitment scores. However, this study also found that prior to 8-months, no differences in 
diabetes management were observed. Another study by Cunningham et al. (2014) concluded that 
current levels of higher engagement predicted smoking quit attempts over the previous year.6 The 
current study assessed health behavior changes after a 3 to 5- month time period, which may be 
too short of a time period to adequately assess change.  
The second aim of this study examined differences in engagement levels between 
individuals with a positive genetic test result and those with no pathogenic variant on a genetic test 
for hereditary cancer syndromes. This study showed that in this patient population, a positive 
genetic test (pathogenic variant) result did not make an individual more or less engaged in their 
health compared to those with a negative or a VUS result (no pathogenic variant). These findings 
might be explained by the implication that both types of genetic testing results can have large 
implications. Discovering that one has a hereditary predisposition to cancer or discovering that 
one has a significantly reduced likelihood of having a hereditary predisposition to cancer may 
equally empower an individual to become more engaged in their health. While no previous studies 
have directly measured engagement levels before and after receiving genetic information, a 
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previous study found that 3-months after receiving genetic susceptibility information by mail, only 
1% of participants in a study had discussed their results with a health care provider.49  
Differences in behavior changes between individuals with a pathogenic variant and those 
with no pathogenic variant was also assessed. The results indicate that knowledge of genetic 
variant status does not make an individual more or less likely to lose weight or quit smoking, but 
additional studies with a larger sample size are needed to draw further conclusions. It should also 
be noted that all participants received counseling about lifestyle modifications to reduce cancer 
risk during their initial genetic counseling appointment despite genetic testing results, so the lack 
of difference in behavior change by variant status may therefore be less impacted by genetic test 
results. Previous studies have been mixed regarding the impact of receiving genetic information 
on behavior change. The findings of this study are consistent with Holland et al. (2016) who 
concluded that receiving genetic information does not change behaviors such as smoking cessation 
and physical activity.54 Other studies have found that receiving genetic information led to 
beneficial health outcomes, such as pursuing risk-reducing health behavior changes and engaging 
in smoking quit attempts.53,56  
2.4.1 Limitation and Future Research 
These findings are limited by several factors. The study included a population of patients from one 
Hereditary GI cancer clinic; therefore, the findings may not be generalizable to other populations. 
Concluding that genetic counseling increases patient engagement is also limited by the lack of a 
control group. It cannot be certain that genetic counseling was the only contributing factor to the 
observed increased engagement scores. Another limitation was the small sample size for 
behavioral data (weight loss and tobacco cessation). Additionally, the findings may be influenced 
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by social desirability on the survey responses. Participants may have felt that they should respond 
to the ACE and the Lifestyle Questionnaires on weight loss and tobacco cessation questions in a 
“socially desirable manner” rather than with the truth, although measures were taken in the 
procedure to administer the survey in a neutral fashion.  
Future directions include conducting the same analyses on different populations, including 
a larger sample size, a population outside of the Hereditary GI clinic, or a population referred to a 
different specialty of genetic counseling. Analyzing differences between a control group, such as 
a patient who only visits with a physician and not a genetic counselor, could provide important 
information about the impact of genetic counseling on health behavior changes and patient 
engagement. Additional analyses could also explore the outcomes of combining the interventions 
of genetic counseling and a health coaching program to expand upon the findings in this study.  
2.5 CONCLUSION 
The association between genetic counseling and increased patient engagement identified in this 
study contributes to the current body of knowledge. Genetic counseling as a service may motivate 
individuals to become more active in their health care. This may, in turn, lead to downstream 
positive effects such as better health care outcomes and lower health care costs that have been 
previously associated with patient engagement. In regards to the health behavior findings, having 
a higher baseline Navigation score within the ACE measure may make one less likely to lose 
weight. Therefore, individuals who are overweight and have a higher Navigation score may require 
additional resources in order to lose weight. However, a larger sample size and a longer assessment 
period may be necessary in order to draw full conclusions. As it was found that a pathogenic variant 
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result did not make an individual more or less engaged in their health compared to those with no 
pathogenic variant, factors related to health behavior changes and engagement levels may be 
complex and might not be influenced solely by receiving genetic information.  
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 RESEARCH SIGNIFICANCE TO GENETIC COUNSELING AND PUBLIC 
HEALTH 
Cancer is the second leading cause of death and accounts for the largest proportion of potential life 
years lost in the United States, making it a significant burden on the health of the population.29 
From 1980 to 2014, 1,518 years of potential life lost before age 75 per 100,000 was attributed to 
cancer.65 The high mortality and morbidity rates of cancer lead to substantial economic burdens 
on the nation. In 2014, around $87.8 billion health care dollars were spent on cancer treatment.29 
However, nearly two thirds of cancer diagnoses, are estimated to be preventable through changes 
in health behavior such as smoking cessation and increased physical fitness.29 Such health behavior 
modifications are a promising area of public health interventions aimed at preventing cancer 
development. Widespread implementation of such interventions could lead to decreased mortality 
and morbidity of cancer in the nation. This study explored several of the many factors that may 
influence an individual’s likelihood to lose weight or quit smoking. As weight loss and tobacco 
cessation are health behavior changes that are known to be associated with reducing cancer risk, 
even amongst a population with a hereditary predisposition to cancer, further understanding of 
what components make an individual more likely to pursue these behaviors has public health 
implications.38,39 If public health interventions are designed to target those who are less likely to 
pursue health behavior changes, it may increase health outcomes and ultimately lead to decreased 
cancer incidences. Such a decrease would especially benefit individuals with hereditary cancer 
syndromes that are associated with high cancer risks. Ultimately, there is the potential to decrease 
the burden of cancer and save significant health care dollars.  
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This study addresses the assessment component of the core essentials of public health, the 
research “analyze[d] the determinants of identified health needs.”66 Genetic counseling was found 
to be a positive determinant for patient engagement. Additionally, having a higher baseline 
Navigation score within the ACE measure may make one less likely to lose weight. Therefore, 
individuals who are overweight and have a higher Navigation score may require additional 
resources in order to lose weight. We also identified that, in the current sample, having a 
pathogenic variant does not make one more or less likely to engage with the health care system 
compared to not having a pathogenic variant. Therefore, genetic variant status was not found to be 
a determinant of patient engagement in this sample.  
In terms of the ten essential public health services, this study fulfills the component of 
“inform[ing], educat[ing], and empower[ing] people about health issues”.66 An additional analysis 
in this paper found that genetic counseling increased patient engagement. There is currently a lack 
of research that examines the influence of genetic counseling on patient engagement. Genetic 
counseling has previously been found to increase empowerment, self-efficacy, knowledge about 
health, satisfaction with health care experiences, and involvement with the health care system.8 
These factors are all related to active participation in one’s health. Further delineating the outcomes 
of genetic counseling is imperative in the field in order to demonstrate the value of genetic 
counseling. If individuals become more active in the health care system after receiving genetic 
counseling, it may lead to further positive downstream outcomes, such as reducing their cancer 
risks through receiving services that decrease the risk of cancer, like colonoscopies. As patient 
engagement has been related to better health outcomes and lower healthcare costs, the service of 
genetic counseling may, in turn, lead to those outcomes as well. This research can serve to help 
identify effective public health interventions that can be integrated into a clinical setting, such as 
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administering the ACE survey to measure a patient’s engagement before their appointment. 
Genetic counselors could use that information to identify individuals at risk for poor health 
outcomes and to further personalize the session by providing additional resources. Ultimately, 
these findings have the potential to improve public health and may lead to lower healthcare costs. 
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 PUBLIC HEALTH ESSAY 
4.1 INTRODUCTION 
Patient engagement is a new field of study that strives to understand the implications of being 
involved in one’s health care.1 The term patient engagement was defined by Gruman et al. (2010) 
as “actions individuals must take to obtain the greatest benefit from the health care services 
available to them.”1 Increased patient engagement can lead to better health outcomes as well as 
lower health care costs and thus better utilization of health care resources. Previous research has 
found that more highly engaged patients were significantly less likely to be obese, to smoke, and 
to have an emergency department visit or a hospital stay within the past 12 months.2 Further, 
patients with lower engagement levels had health care costs that were up to eight times greater 
than those with the higher engagement levels.3  
One measure of patient engagement is the Altarum Consumer Engagement (ACE) 
Measure™ (June 2015), which is a validated patient measure created to provide a comprehensive, 
up to date measurement of a patient’s engagement in their health.15 The ACE measure utilized 
Gruman’s patient engagement definition in order to address all of the factors of engagement. The 
tool has three domains, which are defined as: 
• “Commitment: confidence and ability to maintain a healthy lifestyle and manage 
one’s health. 
• Navigation: confidence and ability to ask about and participate in treatment 
decisions. 
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• Informed Choice: Informed patterns of seeking and using information about health 
and healthcare.”15  
One intervention that has been previously related to increasing patient engagement is health 
coaching.64 Personal health coaching is an intervention designed to help individuals pursue 
behavior changes through creating accountability.64 The research on clinical outcomes of health 
coaching has been mixed, although the majority of the research has concluded that health coaching 
leads to beneficial patient outcomes.67-69 One study found no reported benefits from a health 
coaching intervention.67 Wakefield et al. (2004) examined the differences between a motivational 
interviewing intervention compared to usual care on smoking cessation outcomes in a cohort of 
137 cancer patients in Australia. They found no statistically significant differences between the 
treatment group and the control group. In contrast, many studies have shown that health coaching 
is an effective intervention at promoting health behavior change.68,69 One study assessed the 
outcomes of a 12-week health coaching program addressing diet, physical fitness, and sleep habits 
that was conducted by medical assistants over the phone in a primary care setting.69 A total of 40 
participants completed the program, and 33 participants were weighed by the investigators before 
and after the intervention. It was found that BMI after the intervention was significantly decreased 
compared to prior to the intervention across all 33 participants.69 A similar study by Appel et al. 
(2011) conducted a randomized controlled trial to analyze the outcomes and potential differences 
between in-person health coaching and remotely-delivered, which included telephone calls, an 
informational website, and emails, health coaching. Four hundred and fifteen individuals 
participated in the trial, and it was found that both health coaching delivery models resulted in 
clinically significant weight loss over a two-year period.68 There are fewer studies assessing health 
coaching addressing smoking cessation. A retrospective cohort study compared 241 participants 
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who received tobacco cessation health coaching to two control groups, one group who did not 
receive any intervention and one group who completed a tobacco cessation education course.70 It 
was found that after 12 months, smoking cessation rates among participants who received health 
coaching were significantly higher compared to the control group who received no intervention, 
and were similar compared to the control group who received the education course.70 Regardless 
of the outcomes of health coaching, identifying individuals who might be less likely to pursue a 
health intervention after discussing the option with a health care provider may have implications 
for their care. Providers could target interventions to address some of the underlying issues that 
contribute to their lack of engagement, such as providing more resources or identifying other health 
promoting programs that they may be interested in. 
There are a variety of delivery models for health coaching; the intervention can be 
effectively delivered in person, via telephone, or through online-based programs. Appel et al. 
(2011) reported no statically significant differences between in-person health coaching and 
remotely delivered health coaching.68 Similarly, another study assessed the outcomes of an 
internet-based health coaching program designed to increase discussion between patient and 
provider regarding the patient’s chronic conditions.71 A total of 241 participants were randomly 
assigned to the intervention or to the control group. It was found that participants who completed 
the Internet-based program were significantly more likely to receive advice about their condition 
and referrals to specialists from their health care providers compared to participants who did not 
receive health coaching. 
Coaches of such programs include health care professionals, specially trained personnel, 
and peers. Leahey & Wing (2013) conducted a randomized controlled study to assess differences 
in outcomes between professional, peer, and mentor (an individual who previously lost weight)-
62 
delivered health coaching for obese patients.72 Forty-four participants were randomly assigned to 
a health coaching group.72 Weight loss rates for individuals who received health coaching from a 
professional (56% weight loss) or a peer (50% weight loss) were higher than individuals who 
received health coaching from a mentor (17% weight loss).72 The difference between professional 
and mentor- delivered health coaching was significant.72 This study provided evidence that health 
coaching from either a professional or a peer may be an effective measure. 
In order to integrate additional resources and programs aimed at behavior change, such as 
health coaching, into a physician’s practice, the Agency for Healthcare Research and Quality and 
the Robert Wood Johnson Foundation conducted a national trial involving 17 practice-based 
research networks across the nation.73 The incorporation of additional physician-recommended 
interventions to address health behavior change in a primary care setting were analyzed. These 
interventions concentrated on smoking, unhealthy diet, physical inactivity, and alcohol abuse. The 
project demonstrated a high uptake rate for both provider referrals and patient participation. 
Ultimately, the UPMC Health Plan chose to model a health coaching program based on the Robert 
Wood Johnson Foundation’s program.  
When considering behavior change in the context of public health genetics and genetic 
counseling, it is hypothesized that genetic test results may have an impact on the pursuit of 
interventions like health coaching programs. Although no studies have directly assessed the 
outcome of genetic testing on the likelihood of an individual to pursue a health coaching program, 
previous literature has assessed the health behavior changes of losing weight and quitting smoking 
after receiving genetic testing results. One study found that participants who learned they had the 
APOE ε4 allele, placing them at higher risk for Alzheimer disease, were significantly more likely 
to pursue risk-reducing health behavior changes one year after receiving genetic counseling 
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compared to those who did not have the ε4 allele.56 Similarly, another study found that patients 
who were discovered to have severe alpha-1 antitrypsin deficiency were 3.3 times more likely to 
engage in tobacco quit attempts, were more likely to pursue treatment options and reported 
decreased smoking rates after 3 months compared to those who were carriers and those who were 
unaffected.53 However, the authors did not find any significant results related to tobacco abstinent 
levels after three months, which highlights the complexity of smoking cessation. In contrast, a 
meta-analysis of 18 studies conducted by Hollands et al. (2016) found that genetic information 
(mutations associated with diseases such as cardiac conditions, cancers, diabetes, and Alzheimer’s 
disease) did not have an impact on motivation to pursue risk-modifying behaviors, including 
smoking cessation and physical activity.54 
The purpose of this essay is to understand the factors, including patient engagement and 
genetic variant status, that may make an individual more likely to complete a health intervention 
such as a health coaching program. This essay assessed participant completion of a physician-
prescribed health coaching program, UPMC’s Prescription for Wellness. The program is available 
at no cost to any patient insured by UPMC Health Plan. The goal of the wellness program is to 
help an individual understand and manage their health and navigate the health care system in order 
to improve their health. The program was adapted from an initiative funded by the Agency for 
Healthcare Research and Quality and the Robert Wood Johnson Foundation that demonstrated the 
benefits of a physician partnership with community resources addressing behavior change.64 In 
order to be enrolled in UPMC’s Prescription for Wellness program, a patient’s physician writes 
them a prescription for the appropriate health coaching program. There are a number of programs 
available through UPMC’s Prescription for Wellness including behavioral health, condition 
management, maternity, lifestyle improvement, and shared decision making. In the current study, 
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once a prescription for either a weight loss program or smoking cessation program was given by 
the gastroenterologist, and the patient accepted the prescription, the patient either called the 
program, or a health coach contacted the participant. Health coaches consisted of trained and 
licensed health care professionals. The program consisted of 6-8 weekly phone calls conducted by 
health coaches that were supplemented by educational materials mailed to the participant. Sessions 
addressed the overall goals and concerns for the patient, as well as explored motivations to pursue 
health behavior changes. Other support resources, such as assigned homework or referrals to other 
services were also given when appropriate. 
The first aim of this essay is to evaluate the relationship between an individual’s pre-
counseling engagement in their health and completion of the UPMC Prescription for Wellness 
program. It is hypothesized that individuals who have higher pre-counseling health engagement 
scores will be more likely to complete the UPMC Prescription for Wellness program after given a 
referral compared to individuals who have lower pre-counseling health engagement scores. 
The second aim of this essay is to evaluate the relationship between an individual’s 
variant status and completion of the UPMC Prescription for Wellness program. It is hypothesized 
that individuals who have a positive genetic test result (pathogenic variant) will be more likely to 
complete the Prescription for Wellness program after given a referral compared to individuals 
with no pathogenic variant. 
4.2 PARTICIPANTS 
Participants were recruited from University of Pittsburgh Medical Center (UPMC) Hereditary GI 
Tumor Program’s patient population who underwent genetic counseling for the first time from 
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July, 2016 to December, 2017. In order to receive a referral to the UPMC Prescription for Wellness 
program, participants had to be insured by UPMC Health Plan, and either be overweight (BMI ≥ 
30) or current smokers at the time of their initial appointment. Those who were under the age of 
18 or unable to give informed consent were excluded from the study. Patients were referred to the 
clinic due to a personal history and/or a family history that is concerning for a hereditary 
predisposition to cancer. Indications for referral include young ages of cancer diagnoses, multiple 
primary cancer diagnoses, multiple family members affected with the same or related types of 
cancers, and/or tumor studies indicative of a possible underlying genetic cause.  
4.3 PROCEDURE 
This study was approved by the University of Pittsburgh IRB (PRO16050209, 07/12/16) 
(Appendix A.6). The investigators obtained informed consent for participants who met the study 
criteria and who were interested in participating in the study. Next, the Altarum Consumer 
Engagement (ACE) Measure was delivered verbally to assess individual healthcare engagement.15 
The ACE measure is comprised of 12 statements and utilizes a 5-point Likert scale, ranging from 
“strongly disagree” to “strongly agree” (Appendix A.1).15 It has three different domains, 
Commitment, Navigation, and Informed Choice, with four questions comprising each domain.15 
An average of the four questions per domain was taken and then multiplied by 6.25 to produce a 
total score for each domain ranging from 0-25.15 The final scores for each domain were then 
summed to calculate an individual’s total engagement score ranging from 0-75.15 
After completing the survey, the participants next received genetic counseling and a 
consult with a gastroenterologist who specializes in hereditary GI cancer syndromes. Patients 
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insured by UPMC Health Plan who were overweight (BMI ≥ 30) or were current smokers were 
included in this study and given standard lifestyle modification reading material, as well as a 
Prescription for Wellness to a tobacco cessation or weight loss health coaching program if they 
were interested. When participants were both overweight and current smokers, the 
gastroenterologist and patient discussed which program would be most beneficial. Patients who 
were overweight or used tobacco and had a different insurer were given only the standard of care 
reading material for lifestyle changes. For participants who were given a referral to the 
Prescription for Wellness program, completion status of the program was tracked through the 
Electronic Medical Record or directly discussed with the UPMC Health Plan team.  
The genetic counseling that participants received consisted of a review of cancer and 
genetics, a personalized cancer and genetic risk assessment, information about hereditary cancer 
syndromes, cancer preventive measures and psychosocial counseling. When clinically appropriate, 
genetic testing was discussed and offered. Participants who had genetic testing received the results 
from a genetic counselor by telephone within a three-month time period after their initial 
appointment. Possible results that were reported on patient’s genetic testing reports included 
positive (pathogenic or likely pathogenic variant), a variant of unknown significance (VUS) and 
negative (benign or likely benign variant). All participants were then contacted via phone three to 
five months after their initial office appointment to repeat the ACE measure survey. Individuals 
who were overweight (BMI ≥ 30) and individuals who were current tobacco users at the time of 
their initial visit were also asked to complete the Lifestyle Questionnaires, either the weight loss 
questionnaire or the smoking cessation questionnaire, as appropriate, during the post follow up 
phone call (Figure 12). Individuals who were undergoing cancer treatment during the time of the 
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study were excluded in the health behavior analyses, as active cancer treatment might reduce the 
likelihood that an individual could pursue health behavior changes. 
 
Figure 12. Protocol Flowsheet 
4.4 RESULTS 
Of the 195 participants who completed the study, 116 were not overweight or current smokers and 
they were excluded from the analyses (Figure 13). Thirteen participants were undergoing current 
cancer treatment and were excluded. Twenty-seven participants had a different insurer and did not 
qualify for a Prescription for Wellness. A total of 39 participants qualified for a referral to the 
Prescription for Wellness, either for weight loss (n = 32) or smoking cessation (n = 7). Thirteen 
(13) participants ultimately enrolled and completed the Prescription for Wellness program, either 
for weight loss (n = 10) or smoking cessation (n = 3). Participants ranged from ages 26-78 years 
old (mean age of 49 years) (Table 7). Approximately 97% of participants were Caucasians and 3% 
were African Americans. 56% were females and 44% were males. Their personal cancer history 
was as follows: no cancer (n = 27), colorectal cancer (n = 4), and other cancer (n = 8). Twenty-
nine (29) participants underwent genetic testing.  
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Figure 13. Participant Flowsheet 
 
Table 7. Characteristics of the sample at baseline 
 n % 
Sex   
Female 22 56 
Male 17 44 
Age   
18-34 6 15 
35-51 13 33 
52-64 15      38 
65+ 5 13 
Mean age = 49   
Ethnicity   
= 39 participants included in this study
= 66 participants
Minus 27 who did not have UPMC insurance  
= 79 participants
Minus 13 who were undergoing current cancer tx
195 participants completed the study
Minus 116 who did not have a BMI≥ 30 or were not current smokers 
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Caucasian 38 97 
African American 1 3 
Cancer History   
No cancer 27 69 
Colorectal 4 10 
Pancreatic 1 3 
Other cancer 7 18 
Total 39           100 
 
Two-sample t-tests with equal variances were conducted in order to analyze the effect that 
pre-counseling engagement levels had on whether or not participants completed the Prescription 
for Wellness program. No statistical differences were found between pre-counseling engagement 
levels in participants who did or did not complete the Prescription for Wellness program (p = 
0.151), 95% CI = (-2.082, 13.019) (Table 8) (Figure 14). Likewise, none of the individual domains 
were significantly different between participants who did or did not complete the program (Table 
8). Although there was a small sample size, a multiple logistic regression was run to test 
associations between completion status and pre-counseling engagement (ACE) scores to adjust for 
the covariates of age, gender, and cancer status. No association between pre-counseling 
engagement and completion status was observed after adjustment for covariates.  
 
Table 7 Continued 
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Figure 14. Pre-counseling engagement levels effect on completion of the Prescription for Wellness program 
 
 
Table 8. Summary statistics of pre-counseling engagement levels effect on completion of the Prescription for 
Wellness program 
Averages of Results (n = 39) 
 Coefficient for the 
Completed group 
(n = 12) 
Coefficient for the Did 
not Complete group (n = 
17) 
Difference p-Value 
Navigation 16.987 18.610 1.428 0.263 
Commitment 15.024 16.286 1.262 0.419 
Informed Choice 11.899 14.483 2.584 0.171 
Total 43.910 49.379 5.469 0.151 
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Two-sample t-tests with equal variances were conducted in order to analyze the effect that 
variant status had on completion status in the Prescription for Wellness program. No statistical 
differences were found between variant status and completion status in the Prescription for 
Wellness program (p = 0.572), 95% CI = (-0.266, 0.472) (Table 9 & 10). Although there was a 
small sample size, a multiple logistic regression was run to test the association between completion 
status of the program and variant status to adjust for the covariates of age, gender, and cancer 
status. No association between variant status and completion status was observed after adjustment 
for covariates. 
 
Table 9. Summary statistics of the effect of variant status on completion of the Prescription for Wellness 
program 
Averages of Results (n = 29) 
 Coefficient for the 
Completed group 
(n = 12) 
Coefficient for the Did 
not Complete group (n = 
17) 
Difference p-Value 
Variant Status 0.25 0.353 0.103 0.572 
 
Table 10. Frequencies of variant status and completion of the Prescription for Wellness 
 Pathogenic Variant No Pathogenic Variant Total 
Completed Rx for 
Wellness 
3 9 12 
Did Not Complete Rx 
for Wellness 
6 11 17 
Total 9 20 29 
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4.5 DISCUSSION 
The aims of this study were to evaluate the relationship between an individual’s pre-counseling 
engagement in their health as well as an individual’s genetic variant status and completion status 
of the UPMC Prescription for Wellness program. Although the data demonstrated a trend towards 
increased engagement levels leading to someone being less likely to complete the Prescription for 
Wellness program, this was not statistically significant, and thus no definitive conclusions on an 
association can be determined with this study. Previous studies have found that higher patient 
engagement was associated with beneficial health behaviors, including a healthier body weight 
and lower smoking rates, as well as a better utilization of health care services.2,14 Patient 
engagement has also been found to lead to individuals feeling more in control of their health.13 If 
the trend seen in this data is found to be significant in future studies, one possible explanation is 
that this feeling of control could therefore lead an individual to not feel the need to pursue a health 
coaching program because they may feel they already have all the resources they need to improve 
their health.  However, more research is needed in this area to draw any definitive conclusions.    
The analyses between variant status and completion of the Prescription for Wellness 
demonstrated a trend towards individuals with a negative or a variant of unknown significance 
genetic testing result leading to someone being more likely to complete the Prescription for 
Wellness program. However, the results were not significant thus no definitive conclusions can be 
drawn at this time. The current research on the effect of receiving genetic testing results have been 
mixed. Previous research has concluded that individuals with positive genetic testing results are 
more likely to pursue cancer surveillance services such as colonoscopies and self-breast exams but 
not mammograms.50,48 Although health coaching and cancer surveillance services are both services 
that may help in reducing cancer risk, patients may perceive a more immediate benefit to cancer 
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surveillance services such as colonoscopies when compared to programs like health coaching. This 
perception of benefit may make an individual more likely to pursue cancer surveillance services 
compared to health coaching programs. Furthermore, the findings of this research are consistent  
with another study that found no association between genetic information and pursuing risk-
modifying behaviors, and concluded that genetic testing as an intervention to change health 
behaviors would not be an effective public health approach.54 
The results of this research are limited by different factors, including the small sample size. 
Further, the study included a population of patients from one Hereditary GI cancer clinic; therefore, 
the findings may not be generalizable to other populations. Individual differences outside of patient 
engagement may play a large role in one’s decision on whether or not to pursue a health coaching 
program. For example, culture and values are two determinants of health that may be related to 
health outcomes.74 One study that assessed the relationship between American regional cultures 
and health outcomes analyzed a dataset of cultural distribution among regions in the nation 
compared to life-expectancies by state.75 It was found that certain cultures had lower life 
expectancies.75 In the current study, it can be hypothesized that certain cultures might not feel 
comfortable with a health coach for various reasons. Values can also affect the choice of enrolling 
in a wellness program; if an individual does not think it is important to stop smoking then they 
might not choose to enroll. However, there has not been specific research that has addressed the 
relationship between culture and values and health coaching. 
There are three core functions of public health, which include assessment, policy 
development and assurance.66 This study addresses the assessment component of the core 
function of public health, which is defined as “analyz[ing] the determinants of identified health 
needs.”66  The current study focuses on assessment by assessing factors that may impact an 
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individual’s completion of a prescribed health coaching program, in this case how pre-
counseling engagement scores and genetic test results impact participation in the UPMC 
Prescription for Wellness Program. The results of this study showed that neither an individual’s 
pre-counseling engagement nor genetic variant status was found to be a determinant of whether 
or not someone completed the Prescription for Wellness. There are most likely other factors that 
contribute to an individual’s likelihood to pursue a health coaching program.   
Additionally, health coaching programs like the Prescription for Wellness can serve to 
fulfill one of the ten essential public health services of, “inform[ing], educate[ing], and 
empower[ing] people about health issues”.66 Health coaches provide individualized education and 
support to individuals, which can enhance the evidence-based information that they receive about 
their health condition and empower them to take action to improve their health.  Previous studies 
on health coaching found that the intervention can lead to significant weight loss and tobacco 
cessation rates.68,69 This research found similar findings and also concluded that individuals who 
received genetic counseling as well as enrolled in the Prescription for Wellness health coaching 
program lost more weight than a previous report of individuals who enrolled in the Prescription 
for Wellness who did not receive genetic counseling.64 Therefore, the combined interventions of 
genetic counseling and a health coaching program may lead to beneficial health outcomes.   
 Furthermore, the physician partnership model that the Prescription for Wellness utilizes, 
as it is a physician-prescribed program, addresses the essential service of “link[ing] people to 
needed personal health services and assure the provision of health care when otherwise 
unavailable”.66 The health coaching program provides physicians with an additional resource to 
provide to their patients as an option in managing health problems such as obesity and tobacco 
use. While this study found that completion of a health coaching program was not affected by 
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engagement scores or genetic test results, other factors may be play a role in an individual’s 
likelihood to complete a health coaching program. 
This study demonstrates that collecting information on pre-counseling engagement scores 
and genetic variant status may not be informative as part of an intervention to increase the 
likelihood of an individual completing a health coaching program. However, based on the limited 
sample size of this study, more research is needed in this area. Future directions would include 
sampling a larger population size as well as studying additional factors that may motivate an 
individual to pursue a health coaching program in the context of a genetic counseling clinic. 
Additional factors could include socioeconomic status, an individuals’ type of locus of control 
(internal or external), desire to lose weight, and knowledge of obesity-related health conditions. 
The effect of patient engagement scores on the use of other health interventions commonly 
recommended in the cancer genetic counseling setting could also be addressed, including cancer 
screening services and other referrals made by genetic counselors. The effect of patient 
engagement scores on the extent of cascade testing and cancer screening of relatives that occurs 
after an individual discovers they have a pathogenic variant that causes an increased cancer risk 
would provide information on another important aspect of genetic counseling. Additionally, a 
qualitative research study, utilizing individual interviews or focus groups, would help to gain a 
deeper understanding of a patient’s engagement and willingness to complete a health coaching 
problem. 
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4.6 CONCLUSION 
Patient engagement levels and genetic variant status was not found to make an individual more or 
less likely to complete the Prescription for Wellness program. Motivations to pursue health 
interventions may be complex and multifactorial in nature. Further research to delineate the factors 
that may make an individual more likely to engage in a health intervention could be helpful in 
order to guide intervention development.  
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A.6 IRB APPROVAL LETTER 
 University of Pittsburgh 
Institutional Review Board 
3500 Fifth Avenue 
Ground Level 
Pittsburgh, PA 15213 
(412) 383-1480 
(412) 383-1508 (fax) 
http://www.irb.pitt.edu 
Memorandum 
    
To: Randall Brand, MD 
From: IRB Office  
Date: 10/9/2017  
IRB#: MOD16050209-03  / PRO16050209  
Subject: GI Hereditary Tumor Program and Prescription for Wellness Study  
 
The University of Pittsburgh Institutional Review Board reviewed and approved the requested 
modifications by the expedited review procedure authorized under 45 CFR 46.110 and 21 CFR 
56.110. 
   
Modification Approval Date: 10/9/2017  
Expiration Date: 5/16/2018  
Please note that it is the investigator’s responsibility to report to the IRB any unanticipated 
problems involving risks to subjects or others [see 45 CFR 46.103(b)(5) and 21 CFR 
56.108(b)].  Refer to the IRB Policy and Procedure Manual regarding the reporting requirements 
for unanticipated problems which include, but are not limited to, adverse events.  If you have any 
questions about this process, please contact the Adverse Events Coordinator at 412-383-1480.  
The protocol and consent forms, along with a brief progress report must be resubmitted at least 
one month prior to the renewal date noted above as required by FWA00006790 (University of 
Pittsburgh), FWA00006735 (University of Pittsburgh Medical Center), FWA00000600 
(Children’s Hospital of Pittsburgh), FWA00003567 (Magee-Womens Health Corporation), 
FWA00003338 (University of Pittsburgh Medical Center Cancer Institute).  
  
Please be advised that your research study may be audited periodically by the University of 
Pittsburgh Research Conduct and Compliance Office.  
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APPENDIX B: RESULTS 
 
Table 11. Change in engagement (ACE) scores relationship with weight loss (% change in BMI) in the overall 
cohort 
  
Coefficient Standard 
Error 
p-value 95% Confidence 
Interval 
Univariate Analysis- 
Change in ACE Total -0.032 0.019 0.095 -0.069, 0.006 
Change in ACE 
Commitment 
-0.025 0.040 0.528 -0.105, 0.055 
Change in ACE 
Navigation 
-0.049 0.040 0.222 -0.130, -0.031 
Change in ACE 
Informed Choice 
-0.037 0.030 0.223 -0.096, 0.023 
Multivariate Analysis (including covariates of age, gender, cancer status, and completion 
status of the Prescription for Wellness)- 
Change in ACE Total -0.030 0.019 0.169 -0.065, 0.012 
Change in ACE 
Commitment 
-0.023 0.0397  0.564 -0.103, 0.057 
 
Change in ACE 
Navigation 
-0.040 0.040 0.329 -0.121, 0.042 
Change in ACE 
Informed Choice 
-0.029 0.030 0.339  -0.090, 0.032 
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